No CrossRef data available.
Article contents
Treatment of psychoses in the elderly
Published online by Cambridge University Press: 02 January 2018
Extract
Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Psychotic disorders in the elderly can be divided into three types: disorders that have started in earlier life and persist into old age; disorders that start de novo after the age of 60, and psychoses associated with brain disease, including the dementias. The classification of psychoses in late life has provoked controversy for nearly a century. The debate concerns whether schizophrenia can present at any stage of life or whether functional psychoses, arising for the first time in late life, represent different illnesses. The nomenclature of such disorders consists of numerous terms including late onset schizophrenia, late paraphrenia, paranoid psychosis of late life and schizophreniform psychosis. This plethora of terms has made research difficult to interpret.
- Type
- Research Article
- Information
- Copyright
- Copyright © The Royal College of Psychiatrists 1996
References
Almeida, O. P., Howard, R. J., Levy, R.
et al (1995) Psychotic states arising in late life (late paraphrenia). British Journal of Psychiatry, 166, 205–228.CrossRefGoogle ScholarPubMed
Alvir, J. J., Lieberman, J. A., Safferman, A. Z.
et al (1993) Clozapine induced agranulocytosis; incidence and risk factors in the USA. New England Journal of Medicine, 329, 162–167.CrossRefGoogle Scholar
American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders (3rd edn, revised) (DSM–III–R). Washington, DC: APA.Google Scholar
Bellack, A. S. & Mueser, K. T. (1993) Psychosocial treatment for schizophrenia. Schizophrenia Bulletin, 19, 317–338.CrossRefGoogle ScholarPubMed
Connelly, P. J. (1990) An audit of the use of antipsychotics in a geriatric psychiatry continuing care unit in Scotland. International Journal of Geriatric Psychiatry, 7, 447–454.CrossRefGoogle Scholar
Gerlach, J. (1991) New antipsychotics: classification, efficacy and adverse effects. Schizophrenia Bulletin, 17, 289–309.CrossRefGoogle ScholarPubMed
Goldberg, T. E., Greenburg, R. D., Griffin, S. J.
et al (1993) The effect of clozapine on cognition and psychiatric symptoms in patients with schizophrenia. British Journal of Psychiatry, 162, 43–48.CrossRefGoogle ScholarPubMed
Gottlieb, G. L., McAllister, T. N. & Gur, R. (1988) Depot neuroleptics in the treatment of behavioural disorders in AD. Journal of the American Geriatric Society, 36, 619–621.CrossRefGoogle Scholar
Howard, R. & Levy, R. (1992) Which factors affect treatment response in late paraphrenia?
International Journal of Geriatric Psychiatry, 9, 415–417.Google Scholar
Jeste, D. V. & Wyatt, R. J. (1987) Aging and tardive dyskinesia. In Schizophrenia and Aging (eds Miller, N. E. & Cohen, G. D.) p. 275. New York: Guildford Press.Google Scholar
Jeste, D. V. & Zisook, S. (eds) (1988) Psychosis and depression in the elderly. Psychiatric Clinics of North America, 11, 1–33.Google Scholar
Kane, J., Honigfeld, G., Singer, J.
et al (1988) Clozapine for the treatment resistant schizophrenic: a double-blind comparison versus chlorpromazine/benztropine. Archives of General Psychiatry, 45, 789–796.CrossRefGoogle Scholar
Katona, C. & Levy, R. (eds) (1992) Delusions and Hallucinations in Old Age. London: Gaskell.Google Scholar
Kay, D. W. K. & Roth, M. (1961) Environmental and hereditary factors in the schizophrenia of old age (late paraphrenia) and their bearings on the general problems of causation in schizophrenia. Journal of Mental Sciences, 107, 649–686.CrossRefGoogle ScholarPubMed
Kraepelin, E. (1909) Psychiatrie, Ein Lehrbuch fur Studierende und Artzte (8th ed) Leipzig: Barth.Google Scholar
Lee, M. A., Thompson, P. A. & Meltzer, H. Y. (1994) Effects of clozapine on cognitive function in schizophrenia. Journal of Clinical Psychiatry, 55 (suppl.), 82–87.Google ScholarPubMed
Liberman, R. P. & Corrigan, P. W. (1993) Designing new psychosocial treatments for schizophrenia. Psychiatry, 56, 238–249.CrossRefGoogle ScholarPubMed
Lohr, J. B. & Bracha, H. S. (1988) Association of psychosis and movement disorders in the elderly. Psychiatric Clinics of North America, 11, 61–82.CrossRefGoogle ScholarPubMed
Mayer, W. (1921) On paraphrenic psychoses. Zentralblatt Gesamte Neurologie und Psychiatrie, 71, 187–206.CrossRefGoogle Scholar
McKenna, P. J. & Bailey, P. E. (1993) The strange story of clozapine. British Journal of Psychiatry, 162, 32–38.CrossRefGoogle Scholar
Nygaard, H. A., Brudvik, O. B., Juvik, W. E.
et al (1994) Consumption of psychotropic drugs in nursing home residents. International Journal of Psychiatry, 6, 171–175.Google Scholar
Phanjoo, A. L. (1995) Novel antipsychotics in the elderly. In Developments in Dementia and Functional Disorders in the Elderly (eds Levy, R. & Howard, R.) pp. 151–166. Petersfield: Wrightson.Google Scholar
Pearlson, G., Kreger, L., Rabins, P.
et al (1989) A chart review study of late onset and early onset schizophrenia. American Journal of Psychiatry, 146, 1568–1574.Google ScholarPubMed
Roth, M. (1955) The natural history of mental disorder in old age. Journal of Mental Science, 101, 281–292.CrossRefGoogle ScholarPubMed
Schneider, L. S., Pollock, V. E. & Lyness, S. A. (1990) A meta analysis of controlled trials of neuroleptic treatment in dementia. Journal of American Geriatric Society, 38, 553–563.CrossRefGoogle ScholarPubMed
Szabadi, E. (1995) Adverse reaction profile of antipsychotic drugs. Prescribers Journal, 35, 37–44.Google Scholar
World Health Organization (1992) The Tenth Revision of the International Classification of Diseases and Related Health Problems (ICD-10). Geneva: WHO.Google Scholar
You have
Access
eLetters
No eLetters have been published for this article.